Savaria (Savaria) Interest Expense : $-16.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Savaria Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Savaria's interest expense for the three months ended in Mar. 2024 was $ -3.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-16.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Savaria's Operating Income for the three months ended in Mar. 2024 was $ 12.2 Mil. Savaria's Interest Expense for the three months ended in Mar. 2024 was $ -3.5 Mil. Savaria's Interest Coverage for the quarter that ended in Mar. 2024 was 3.54. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Savaria Interest Expense Historical Data

The historical data trend for Savaria's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savaria Interest Expense Chart

Savaria Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-3.76

-2.71

-9.26

-12.11

-17.33

Savaria Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-4.18	-4.64	-4.70	-3.73	-3.45

Savaria Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.5 Mil.

Savaria (OTCPK:SISXF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Savaria's Interest Expense for the three months ended in Mar. 2024 was $-3.5 Mil. Its Operating Income for the three months ended in Mar. 2024 was $12.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $229.1 Mil.

Savaria's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	12.212	/	-3.452
	=	3.54

The higher the ratio, the stronger the company's financial strength is.

Savaria (Savaria) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Savaria Corp (OTCPK:SISXF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

S97:Germany SIS:Canada

Address

4350 Autoroute Chomedey, Laval, QC, CAN, H7R 6E9

Website

https://www.savaria.com

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are the Accessibility, Adapted Vehicles, and Patient Handling, divisions. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Adapted Vehicle segment adapts vans to be wheelchair accessible for people with mobility challenges. The Patient Handling segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market.